Figure 5From: A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors Impact of MEK inhibition on the RAS signature across 10 lung cancer cell lines. The Y-axis shows the RAS signature score in drug treated cell lines relative to vehicle treated controls.Back to article page